The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

Gen Z is turning into Gen Ozempic. A new survey reveals that many young Americans are planning to turn to weight loss medications, such as Ozempic and Wegovy, to help achieve their goals.

The active ingredient in new drugs like Ozempic, Wegovy and Zepbound mimics a natural hormone that slows digestion and signals fullness to the brain. Around seven million Americans take these ...

These days, it feels like everyone is using Ozempic. The results have been astonishing: The average person taking Ozempic loses about 15 pounds after three months and 27 pounds after six months.

On Christmas Day, Elon Musk turned heads with a decadent photo by his tree. Dressed head-to-toe in a Santa costume, he ...

Ozempic (semaglutide) has potential interactions with other drugs and some supplements. For example, Ozempic can interact with oral medications and some diabetes medications, including insulin ...

Trend No. 1: GLP-1s. These drugs go by names like Ozempic or Wegovy. They have been around for nearly 20 years, with early formulations used exclusively to treat people with diabetes. But recent ...

the active ingredient in Ozempic. Both are sold by Danish drug giant Novo Nordisk. The generic liraglutide is sold by Hikma Pharmaceuticals USA, and a spokesman told CNN by email that the company ...

The new drug, sold under the name Victoza and made by Hikma Pharmaceuticals USA Inc., follows the approval ... sold for diabetes and weight loss as Ozempic and Wegovy by Novo Nordisk and Mounjaro ...